Cargando…

Dysregulation of the Amniotic PPARγ Pathway by Phthalates: Modulation of the Anti-Inflammatory Activity of PPARγ in Human Fetal Membranes

Phthalates are reprotoxic pollutants that are omnipresent in the environment. Detectable in amniotic fluid, these compounds (with the most concentrated being mono-2-ethylhexyl phthalate (MEHP)) are in direct contact with fetal membranes (FMs). They can lead to the premature rupture of FMs by deregul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Antoine, Audrey, De Sousa Do Outeiro, Coraline, Charnay, Coline, Belville, Corinne, Henrioux, Fanny, Gallot, Denis, Blanchon, Loïc, Minet-Quinard, Régine, Sapin, Vincent
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9029737/ https://www.ncbi.nlm.nih.gov/pubmed/35455039 http://dx.doi.org/10.3390/life12040544

Ejemplares similares

Cigarette Smoke Condensate Exposure Induces Receptor for Advanced Glycation End-Products (RAGE)-Dependent Sterile Inflammation in Amniotic Epithelial Cells
por: Choltus, Helena, et al.
Publicado: (2021)

Inflammation of Dry Eye Syndrome: A Cellular Study of the Epithelial and Macrophagic Involvement of NFAT5 and RAGE
por: Henrioux, Fanny, et al.
Publicado: (2023)

Human Amnion Epithelial Cells (AECs) Respond to the FSL-1 Lipopeptide by Engaging the NLRP7 Inflammasome
por: Lavergne, Marilyne, et al.
Publicado: (2020)

Occurrence of a RAGE-Mediated Inflammatory Response in Human Fetal Membranes
por: Choltus, Héléna, et al.
Publicado: (2020)

Dysregulation of Receptor for Advanced Glycation End Products (RAGE) Expression as a Biomarker of Keratoconus
por: Navel, Valentin, et al.
Publicado: (2022)

Pathophysiological Implication of Pattern Recognition Receptors in Fetal Membranes Rupture: RAGE and NLRP Inflammasome
por: Choltus, Helena, et al.
Publicado: (2021)

PPARγ in Neuroblastoma
por: Peri, Alessandro, et al.
Publicado: (2008)

Emerging PPARγ-Independent Role of PPARγ Ligands in Lung Diseases
por: Kulkarni, Ajit A., et al.
Publicado: (2012)

PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
por: Vella, Veronica, et al.
Publicado: (2017)

PPARγ and Apoptosis in Cancer
por: Elrod, Heath A., et al.
Publicado: (2008)

PPARγ, neuroinflammation, and disease
por: Mrak, Robert E, et al.
Publicado: (2004)

Nutraceuticals as Ligands of PPARγ
por: Penumetcha, Meera, et al.
Publicado: (2012)

PPARγ and Cognitive Performance
por: d’Angelo, Michele, et al.
Publicado: (2019)

Phosphorylation of PPARγ Affects the Collective Motions of the PPARγ-RXRα-DNA Complex
por: Lemkul, Justin A., et al.
Publicado: (2015)

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008)

Retinoids regulate human amniotic tissue-type plasminogen activator gene by a two-step mechanism
por: Borel, Valerie, et al.
Publicado: (2010)

Comparative Gene Expression Profiles Induced by PPARγ and PPARα/γ Agonists in Human Hepatocytes
por: Rogue, Alexandra, et al.
Publicado: (2011)

Scaffold-Based Pan-Agonist Design for the PPARα, PPARβ and PPARγ Receptors
por: Zhang, Li-Song, et al.
Publicado: (2012)

PPARγ and MEK Interactions in Cancer
por: Burgermeister, Elke, et al.
Publicado: (2008)

PPARγ and Proline Oxidase in Cancer
por: Phang, James M., et al.
Publicado: (2008)

The Role of PPARγ in Hepatocellular Carcinoma
por: Borbath, Ivan, et al.
Publicado: (2008)

Nuclear receptor corepressors and PPARγ
por: Cohen, Ronald N.
Publicado: (2006)

PPARγ in Kidney Physiology and Pathophysiology
por: Kiss-Tóth, Éva, et al.
Publicado: (2008)

PPARγ tackles treacherous T cells
por: Leslie, Mitch
Publicado: (2009)

Effects of PPARγ Ligands on Leukemia
por: Tabe, Yoko, et al.
Publicado: (2012)

Gastrointestinal Cytoprotection by PPARγ Ligands
por: Naito, Yuji, et al.
Publicado: (2010)

PPARγ in Inflammatory Bowel Disease
por: Annese, Vito, et al.
Publicado: (2012)

Prostaglandins as PPARγ Modulators in Adipogenesis
por: Fujimori, Ko
Publicado: (2012)

The Role of PPAR-γ in Allergic Disease
por: Stark, Julian M., et al.
Publicado: (2021)

Physiological TLR4 regulation in human fetal membranes as an explicative mechanism of a pathological preterm case
por: Belville, Corinne, et al.
Publicado: (2022)

Underexpression of peroxisome proliferator-activated receptor (PPAR)γ in PAX8/PPARγ-negative thyroid tumours
por: Marques, A R, et al.
Publicado: (2004)

Expression of peroxisome proliferator-activated receptor (PPAR)γ in gastric cancer and inhibitory effects of PPARγ agonists
por: Sato, H, et al.
Publicado: (2000)

PPARα/γ-Independent Effects of PPARα/γ Ligands on Cysteinyl Leukotriene Production in Mast Cells
por: Yamashita, Masamichi
Publicado: (2008)

The PPARα and PPARγ Epigenetic Landscape in Cancer and Immune and Metabolic Disorders
por: Porcuna, Jesús, et al.
Publicado: (2021)

Obesity-linked phosphorylation of PPARγ by cdk5 is a direct target of the anti-diabetic PPARγ ligands
por: Choi, Jang Hyun, et al.
Publicado: (2010)

PPARγ activation but not PPARγ haplodeficiency affects proangiogenic potential of endothelial cells and bone marrow-derived progenitors
por: Kotlinowski, Jerzy, et al.
Publicado: (2014)

Structure-Based Virtual Screening and Discovery of New PPARδ/γ Dual Agonist and PPARδ and γ Agonists
por: Maltarollo, Vinicius G., et al.
Publicado: (2015)

Ups and downs: The PPARγ/p-PPARγ seesaw of follistatin-like 1 and integrin receptor signaling in adipogenesis
por: Fang, Dongliang, et al.
Publicado: (2021)

Synergistic Antiproliferative Effects of Combined γ-Tocotrienol and PPARγ Antagonist Treatment Are Mediated through PPARγ-Independent Mechanisms in Breast Cancer Cells
por: Malaviya, Abhita, et al.
Publicado: (2014)

PPAR-γ: Therapeutic Potential for Multiple Sclerosis
por: Drew, Paul D., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_armn4p7gq6s021v9d7gc1si391